Header Logo

Connection

HUBERT HSING CHUANG to Hematologic Diseases

Back to Details
This is a "connection" page, showing publications HUBERT HSING CHUANG has written about Hematologic Diseases.
HUBERT HSING CHUANG
Connection Strength
0.026
Hematologic Diseases
  1. Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma. Br J Haematol. 2013 Dec; 163(5):611-20.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.